In support of the Aβ amyloid hypothesis for AD pathogenesis, BACE1 is theorized to cleave APP into Aβ plaques within Golgi endosomes and lysosomes, thus making the enzyme a potential modulation site to reduce neurodegenerative effects of Aβ plaques [46]. This evidence concerns the gene BACE1 and Alzheimer disease.